Cardiac outflow tract anomalies

被引:74
作者
Neeb, Zachary [1 ]
Lajiness, Jacquelyn D. [1 ]
Bolanis, Esther [1 ]
Conway, Simon J. [1 ]
机构
[1] Indiana Univ Sch Med, HB Wells Ctr Pediat Res, Dev Biol & Neonatal Med Program, Indianapolis, IN 46202 USA
关键词
D O I
10.1002/wdev.98
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The mature outflow tract (OFT) is, in basic terms, a short conduit. It is a simple, although vital, connection situated between contracting muscular heart chambers and a vast embryonic vascular network. Unfortunately, it is also a focal point underlying many multifactorial congenital heart defects (CHDs). Through the use of various animal models combined with human genetic investigations, we are beginning to comprehend the molecular and cellular framework that controls OFT morphogenesis. Clear roles of neural crest cells (NCC) and second heart field (SHF) derivatives have been established during OFT formation and remodeling. The challenge now is to determine how the SHF and cardiac NCC interact, the complex reciprocal signaling that appears to be occurring at various stages of OFT morphogenesis, and finally how endocardial progenitors and primary heart field (PHF) communicate with both these colonizing extra-cardiac lineages. Although we are beginning to understand that this dance of progenitor populations is wonderfully intricate, the underlying pathogenesis and the spatiotemporal cell lineage interactions remain to be fully elucidated. What is now clear is that OFT alignment and septation are independent processes, invested via separate SHF and cardiac neural crest (CNC) lineages. This review will focus on our current understanding of the respective contributions of the SHF and CNC lineage during OFT development and pathogenesis. (C) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:499 / 530
页数:32
相关论文
共 170 条
[1]  
Mitchell S.C., Korones S.B., Berendes H.W., Congenital heart disease in 56,109 births. Incidence and natural history, Circulation, 43, pp. 323-332, (1971)
[2]  
Hoffman J.I., Kaplan S., The incidence of congenital heart disease, J Am Coll Cardiol, 39, pp. 1890-1900, (2002)
[3]  
van der Linde D., Konings E.E., Slager M.A., Witsenburg M., Helbing W.A., Takkenberg J.J., Roos-Hesselink J.W., Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis, J Am Coll Cardiol, 58, pp. 2241-2247, (2011)
[4]  
Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., Et al., Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 113, (2006)
[5]  
Conway S.J., Kruzynska-Frejtag A., Kneer P.L., Machnicki M., Koushik S.V., What cardiovascular defect does my prenatal mouse mutant have, and why?, Genesis, 35, pp. 1-21, (2003)
[6]  
Sadler T.W., Langman J., Langman's Essential Medical Embryology, (2005)
[7]  
Schoenwolf G.C., Larsen W.J., Larsen's Human Embryology, (2009)
[8]  
Garg V., Molecular genetics of aortic valve disease, Curr Opin Cardiol, 21, pp. 180-184, (2006)
[9]  
Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., Yutzey K.E., Extracellular matrix remodeling and organization in developing and diseased aortic valves, Circ Res, 98, pp. 1431-1438, (2006)
[10]  
MacGrogan D., Luna-Zurita L., de la Pompa J.L., Notch signaling in cardiac valve development and disease, Birth Defects Res A Clin Mol Teratol, 91, pp. 449-459, (2011)